TrialInvestigational new drugs2012

A phase I/II study of the Src inhibitor saracatinib (AZD0530) in combination with gemcitabine in advanced pancreatic cancer.

Daniel J Renouf et al.PubMed ↗Publisher ↗

No numbers read from the abstract.